Identification of RUVBL2 as a novel biomarker to predict the prognosis and drug sensitivity in multiple myeloma based on ferroptosis genes
Background Multiple myeloma (MM) is a hematological malignancy with the proliferation of malignant plasma cells. Numerous studies have highlighted the critical role of ferroptosis in MM. However, how to use ferroptosis-related genes (FRGs) for prognostic prediction and treatment guidance in MM remai...
Saved in:
| Main Authors: | Sishi Tang, Xinyi Long, Fangfang Li, Siyi Jiang, Yunfeng Fu, Jing Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2467499 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A study to identify novel biomarkers associated with multiple myeloma
by: Bhaskar Kalarani Iyshwarya, et al.
Published: (2023-11-01) -
Meta-analysis of microarray data to identify potential signature genes and MiRNAs associated with the pathogenesis of asthma
by: Asma Vafadar, et al.
Published: (2025-07-01) -
Integrating machine learning and bioinformatics approaches to identify novel diagnostic gene biomarkers for diabetic mice
by: Weibin Wu, et al.
Published: (2025-07-01) -
Prognostic and diagnostic value of PVR gene and protein levels, serum amylase, and urinary IGFBP-7 and TIMP-2 biomarkers in multiple myeloma
by: Eman M. Habib, et al.
Published: (2025-05-01) -
Candidate target genes in sepsis diagnosis and therapy: identifying hub genes with a spotlight on KLRB1
by: Wang Chen, et al.
Published: (2025-03-01)